Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 11, 2009, Pages 1588-1596

  Brandt, C ^a   Pavlovic, V ^a   Radbruch, A ^a,b   Worm, M ^b   Baumgrass, R ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atopic dermatitis; Cyclosporine a; Foxp3; Interleukin 2; T cell activation

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 7 RECEPTOR;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; CYCLOSPORINE; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349858128     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02054.x     Document Type: Article

References (38)

1. Soderhall C, Marenholz I, Kerscher T, Ruschendorf F, Esparza-Gordillo J, Worm M et al. Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol 2007 5 : e242.
2. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 113 : 651 657.
3. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993 186 : 23 31.
4. Seneviratne SL, Black AP, Jones L, Bailey AS, Ogg GS. The role of skin-homing T cells in extrinsic atopic dermatitis. QJM 2007 100 : 19 27.
5. Santamaria-Babi LF. CLA(+) T cells in cutaneous diseases. Eur J Dermatol 2004 14 : 13 18.
6. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2007 21 : 606 619.
7. Liu J, Farmer JD Jr., Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991 66 : 807 815.
8. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992 13 : 136 142.
9. Berth-Jones J, Graham-Brown RA, Marks R, Camp RD, English JS, Freeman K et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997 136 : 76 81.
10. Taylor A, Verhagen J, Akdis CA, Akdis M. T regulatory cells and allergy. Microbes Infect 2005 7 : 1049 1055.
11. Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005 116 : 949 959 quiz 960.
12. Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004 113 : 756 763.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980 42 : 44 47.
14. Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999 68 : 1356 1361.
15. Baumgrass R, Zhang Y, Erdmann F, Thiel A, Weiwad M, Radbruch A et al. Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression. J Biol Chem 2004 279 : 2470 2479.
16. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006 118 : 178 189. (Pubitemid 43946487)
17. Picker LJ. Control of lymphocyte homing. Curr Opin Immunol 1994 6 : 394 406.
18. Schulz F, Marenholz I, Folster-Holst R, Chen C, Sternjak A, Baumgrass R et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol 2007 120 : 1097 1102.
19. Jiang S, Lechler RI. CD4+CD25+ regulatory T cell therapy for allergy, autoimmune disease and transplant rejection. Inflamm Allergy Drug Targets 2006 5 : 239 242.
20. Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor. Immunology 2005 116 : 103 111.
21. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006 117 : 176 183.
22. Vukmanovic-Stejic M, McQuaid A, Birch KE, Reed JR, Macgregor C, Rustin MH et al. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T cell proliferation in patients with atopic dermatitis. Br J Dermatol 2005 153 : 750 757.
23. Maggi L, Santarlasci V, Liotta F, Frosali F, Angeli R, Cosmi L et al. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007 120 : 429 436.
24. Akdis M, Akdis CA, Weigl L, Disch R, Blaser K. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol 1997 159 : 4611 4619.
25. Caproni M, Torchia D, Antiga E, Volpi W, del Bianco E, Fabbri P. The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis. J Clin Immunol 2006 26 : 370 375.
26. Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J et al. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum 2007 56 : 1910 1920.
27. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 2006 177 : 4488 4494.
28. Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin SF. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 2007 16 : 13 21.
29. Mantel PY, Ouaked N, Ruckert B, Karagiannidis C, Welz R, Blaser K et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006 176 : 3593 3602.
30. Coenen JJ, Koenen HJ, van Rijssen E, Kasran A, Boon L, Hilbrands LB et al. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplant 2007 39 : 537 545.
31. Wang H, Zhao L, Sun Z, Sun L, Zhang B, Zhao Y. A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. Transplantation 2006 82 : 1484 1492.
32. Filantenkov A, Schmidt H, Reutzel-Selke A, Seifert M, Doebis C, Jurisch A et al. Initial organ engraftment with a short-term low-dose CyA treatment induces tolerance for consecutive grafts in a model of strong histoincompatibility. Transplant Proc 2002 34 : 2895 2896.
33. Lu X, Zhou L, Chen S. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice. Transplant Proc 2004 36 : 2429 2431.
34. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007 357 : 2562 2575.
35. Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 2006 212 : 86 98.
36. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005 6 : 1219 1227.
37. Robinson DS, Larche M, Durham SR. Tregs and allergic disease. J Clin Invest 2004 114 : 1389 1397.
38. Taams LS, Palmer DB, Akbar AN, Robinson DS, Brown Z, Hawrylowicz CM. Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology 2006 118 : 1 9.